Related Experiment Video
Updated: May 8, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Replicative senescence in kidney aging, renal disease, and renal transplantation
1Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium. maarten.naesens@uzleuven.be
Abstract:
Cellular or replicative senescence is classically seen as the key element of aging. In renal disease and after kidney transplantation, there is increasing evidence that replicative senescence pathways (p53 and p16) play a central role in disease progression and graft outcome, independent of chronological age. In this review, we summarize the current concepts in the molecular mechanisms of cellular senescence, and correlate these theories with the available literature on aging of native kidneys, kidney diseases, and outcome of renal allografts. Recent data illustrate the complex biology of senescence in vivo, and disprove the concept that senescence is an intrinsic injury process with immanent deleterious consequences. Senescence acts as a homeostatic mechanism that can even limit renal fibrosis, at least in animal studies. In a human setting, it remains to be investigated whether cellular senescence plays an active or a bystander role in fibrogenesis and atrophy of renal tissue.
Insights
Cellular senescence, involving pathways like p53 and p16, impacts kidney disease and transplant outcomes. While traditionally viewed as aging
Area of Science:
- Gerontology and Nephrology
- Cellular Biology and Molecular Mechanisms
Background:
- Cellular senescence is a key aging hallmark.
- Replicative senescence pathways (p53, p16) are implicated in kidney disease and transplantation outcomes, irrespective of chronological age.
Purpose of the Study:
- To review molecular mechanisms of cellular senescence.
- To correlate senescence theories with kidney aging, disease, and allograft outcomes.
Main Methods:
- Literature review and synthesis of current concepts.
- Correlation of in vivo senescence biology with clinical and preclinical data.
Main Results:
- Senescence has complex in vivo biology, challenging its view as solely detrimental.
- Senescence may limit renal fibrosis, as suggested by animal studies.
Conclusions:
- Senescence's role in kidney aging and disease is multifaceted.
- Further investigation is needed to clarify senescence's active or bystander role in human renal fibrogenesis and atrophy.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Nephrons
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy

